XSS in Bdtask G-Prescription Gynaecology \& Obs Consultation

CVE-2024-2276

A vulnerability has been found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as problematic. Affected by this vulnerability is an unknown functionality of the file /Venue_controller/edit_venue/ of the component Edit Venue Page. The manipulation of the argument Venue map leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-256045 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Vulnerability class: XSS (Cross-Site Scripting)

Published · last modified .

CVSS v3 metric

CVSS v3 base score 2.4 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N.

EPSS exploit prediction

EPSS: 0.005 (39.5th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 40th percentile — 39.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2024-2276: held from 0.005 to 0.005.

EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000

Affected products

Weakness classification (CWE)

Public proof-of-concept exploits

References

Frequently asked questions

What is CVE-2024-2276?
CVE-2024-2276 is a low-severity vulnerability in Bdtask G-Prescription Gynaecology \& Obs Consultation, classified under Cross-site Scripting. CVSS score: 2.4/10. Published 2024-03-08.
How severe is CVE-2024-2276?
Low severity. CVSS v3 base score is 2.4 out of 10.
Is CVE-2024-2276 known to be exploited?
1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.